Amylyx Pharmaceuticals
NEWS
Besides providing a sense of hope for children with this devastating disease, this research could offer another clue toward unlocking the mystery behind other forms of ALS.
Not everyone is so confident that Aduhelm will transform the Alzheimer’s drug development landscape.
It was a relatively quiet week in terms of clinical trial news, but there were some significant releases. Here’s a look.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers and Shakers.
JOBS
IN THE PRESS